Clinical Trials Logo
  1. Home
  2. Partial Epilepsy
  3. NCT00465517

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Partial Epilepsy Clinical Trial

Official title:
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Ganaxolone as add-on Therapy in Adult Subjects With Epilepsy Consisting of Uncontrolled Partial-onset Seizures.

Clinical Trial Summary

The study will evaluate the effectiveness and safety of an investigational drug-ganaxolone - on partial seizure frequency in adults with epilepsy taking a maximum of 3 antiepileptic medications (AEDs). The study will also evaluate the effectiveness of ganaxolone in females with catamenial epilepsy. Catamenial epilepsy refers to a relationship between seizure frequency and a woman's menstrual cycle, where the number of seizures increases around the time of a woman's menstrual cycle.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00465517
Study type Interventional
Source Marinus Pharmaceuticals
Contact
Status Completed
Phase Phase 2
Start date February 2007
Completion date November 2008
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT00982787 - Safety and Anticonvulsant Efficacy of Passiflora Incarnata Extract in Patients With Partial Epilepsy Phase 2
Completed NCT00898560 - Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive Phase 1
Recruiting NCT01735032 - Multimodal Imaging in Pre-surgical Evaluation of Epilepsy N/A
Completed NCT01090934 - Localizing the Epileptogenic Zone With High Resolution Electroencephalography N/A
Terminated NCT00391534 - EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy Phase 3
Terminated NCT01496612 - Buspirone Therapy for Localized Epilepsy Phase 2
Completed NCT00900237 - Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine Phase 1
Recruiting NCT04903314 - Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures Phase 1
Completed NCT01373190 - Thermographic Examination of Skin Temperatures in Individuals With Focal Onset Epilepsy N/A
Completed NCT00894478 - Improving Lesion Detection in Children With Magnetic Resonance Imaging (MRI)-Negative Partial Epilepsy Using Diffusion Tensor Imaging N/A
Recruiting NCT03478852 - Investigating Epilepsy: Screening and Evaluation
Recruiting NCT01273129 - Surgery as a Treatment for Medically Intractable Epilepsy
Completed NCT00001666 - Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy N/A
Completed NCT00001932 - Serotonin Receptors in Seizure Disorders N/A
Completed NCT00908349 - Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy Phase 3
Completed NCT02076698 - Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy Phase 3
Completed NCT00706160 - Language Mapping in Patients With Epilepsy
Completed NCT01397968 - Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures Phase 2
Completed NCT01866111 - A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures Phase 2
Completed NCT00957047 - Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy Phase 3